TABLE 1.
Sociodemographic and clinical characteristics of the study cohort.
| Characteristics | Normotensive pregnant control group | Gestational hypertension group | Preeclampsia group | P value | |
|---|---|---|---|---|---|
| Age (years) | 27.25 ± 2.71 | 29.86 ± 4.44 | 27.43 ± 3.60 | 0.231 | |
| Height (cm) | 158.25 ± 5.39 | 159.36 ± 4.07 | 158.57 ± 6.05 | 0.885 | |
| Body weight (kg) | 72.13 ± 7.85 | 77.75 ± 8.55 | 68.44 ± 10.97 | 0.084 | |
| Body mass index (BMI, kg/m2) | 28.13 ± 4.08 | 30.67 ± 3.67 | 27.38 ± 5.02 | 0.215 | |
| Systolic blood pressure (mmHg) | 114.38 ± 8.48 | 132.93 ± 14.89 | 135.57 ± 18.15 | 0.008 | |
| Diastolic blood pressure (mmHg) | 71.38 ± 6.57 | 92.36 ± 10.05 | 90.71 ± 12.50 | <0.001 | |
| Gestational age (weeks) | 37.21 ± 2.05 | 37.39 ± 2.41 | 37.36 ± 1.49 | 0.975 | |
| Gravidity | 1.70 ± 0.82 | 2.13 ± 1.46 | 2.10 ± 0.99 | 0.8 | |
| Parity | 0.40 ± 0.52 | 0.47 ± 0.64 | 0.40 ± 0.52 | 0.96 | |
| Fasting blood glucose (mmol/L) | 4.73 ± 0.50 | 4.83 ± 0.54 | 4.57 ± 0.43 | 0.473 | |
| Uric acid (μmol/L) | 232.73 ± 26.39 | 335.16 ± 69.96 | 359.27 ± 119.52 | 0.0016 | |
| Urine protein grade, n (%) | Grade 0 | 11 (100.0%) | 13 (86.7%) | 2 (20.0%) | <0.001 |
| Grade 1 | 0 (0.0%) | 2 (13.3%) | 5 (50.0%) | ||
| Grade 2 | 0 (0.0%) | 0 (0.0%) | 2 (20.0%) | ||
| Grade 3 | 0 (0.0%) | 0 (0.0%) | 1 (10.0%) | ||
| 24-h urinary protein excretion (mg/24 h) | 113.55 ± 36.21 | 184.14 ± 159.25 | 2064.48 ± 1859.39 | <0.001 | |
Categorical variables are expressed as n (%), continuous variables are expressed as mean ± standard deviation.